155 related articles for article (PubMed ID: 1828962)
1. Tropisetron plus haloperidol to ameliorate nausea and vomiting associated with high-dose alkylating agent cancer chemotherapy.
Bregni M; Siena S; Di Nicola M; Bonadonna G; Gianni AM
Eur J Cancer; 1991; 27(5):561-5. PubMed ID: 1828962
[TBL] [Abstract][Full Text] [Related]
2. Optimal combination therapy with tropisetron in 445 patients with incomplete control of chemotherapy-induced nausea and vomiting.
Hulstaert F; Van Belle S; Bleiberg H; Canon JL; Dewitte M; Buyse M; De Keyser P; Westelinck KJ
J Clin Oncol; 1994 Nov; 12(11):2439-46. PubMed ID: 7964961
[TBL] [Abstract][Full Text] [Related]
3. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
Sorbe BG
Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
[TBL] [Abstract][Full Text] [Related]
4. Optimal combination therapy with Navoban (tropisetron) in patients with incomplete control of chemotherapy-induced nausea and vomiting. The Belgian Navoban Group.
Van Belle SJ; Cocquyt VF; Bleiberg H; Canon JL; Buyse M; Hulstaert F; De Witte M; De Keyser P; Westelinck K
Anticancer Drugs; 1995 Feb; 6 Suppl 1():22-30. PubMed ID: 7749166
[TBL] [Abstract][Full Text] [Related]
5. Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents.
Bruntsch U; Drechsler S; Eggert J; Gosse H; Ukena D; Imhoff W; Faerber L
Semin Oncol; 1994 Oct; 21(5 Suppl 9):7-11. PubMed ID: 9113120
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the efficacy of tropisetron versus a metoclopramide cocktail based on the intensity of cisplatin-induced emesis.
Chang TC; Hsieh F; Lai CH; Tseng CJ; Cheng HH; Li CL; Michael BJ; Soong YK
Cancer Chemother Pharmacol; 1996; 37(3):279-85. PubMed ID: 8529290
[TBL] [Abstract][Full Text] [Related]
7. The anti-emetic efficacy and tolerability of tropisetron in patients conditioned with high-dose chemotherapy (with and without total body irradiation) prior to bone marrow transplantation.
Or R; Drakos P; Nagler A; Naparstek E; Kapelushnik J; Cass Y
Support Care Cancer; 1994 Jul; 2(4):245-8. PubMed ID: 8087443
[TBL] [Abstract][Full Text] [Related]
8. Tropisetron. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential as an antiemetic.
Lee CR; Plosker GL; McTavish D
Drugs; 1993 Nov; 46(5):925-43. PubMed ID: 7507039
[TBL] [Abstract][Full Text] [Related]
9. The anti-emetic efficacy of tropisetron plus dexamethasone in patients treated with high-dose chemotherapy and stem cell transplantation.
Barbounis V; Koumakis G; Hatzichristou H; Vassilomanolakis M; Tsoussis S; Efremidis A
Support Care Cancer; 1999 Mar; 7(2):79-83. PubMed ID: 10089087
[TBL] [Abstract][Full Text] [Related]
10. Tropisetron (Navoban) compared with alizapride in the control of emesis induced by cyclophosphamide-containing regimens.
De Nigris A; Paladini G; Giosa F; Sfeir C; Pagan MG; Maltoni C
Eur J Cancer; 1994; 30A(12):1902-3. PubMed ID: 7880624
[No Abstract] [Full Text] [Related]
11. [The clinical effect of Tropisetron in the prevention of nausea and vomiting induced by anti-cancer drugs].
Wang J; Yang L; Cui C
Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):251-3. PubMed ID: 11783100
[TBL] [Abstract][Full Text] [Related]
12. Tropisetron in the prevention of acute nausea and vomiting in patients treated with high dose epirubicin.
Nicolaides C; Giannakakis T; Skarlos D; Athanassiadis A; Fountzilas G; Damigos D; Pavlidis N
J Exp Clin Cancer Res; 1998 Mar; 17(1):71-5. PubMed ID: 9646236
[TBL] [Abstract][Full Text] [Related]
13. Randomized, double-blind trial comparing the antiemetic effect of tropisetron plus metopimazine with tropisetron plus placebo in patients receiving multiple cycles of multiple-day cisplatin-based chemotherapy.
Herrstedt J; Sigsgaard TC; Nielsen HA; Handberg J; Langer SW; Ottesen S; Dombernowsky P
Support Care Cancer; 2007 Apr; 15(4):417-26. PubMed ID: 17093916
[TBL] [Abstract][Full Text] [Related]
14. Tropisetron: an update of its use in the prevention of chemotherapy-induced nausea and vomiting.
Simpson K; Spencer CM; McClellan KJ
Drugs; 2000 Jun; 59(6):1297-315. PubMed ID: 10882164
[TBL] [Abstract][Full Text] [Related]
15. Tropisetron compared with a metoclopramide-based regimen in the prevention of chemotherapy-induced nausea and vomiting.
Anderson H; Thatcher N; Howell A; Logan K; Sage T; de Bruijn KM
Eur J Cancer; 1994; 30A(5):610-5. PubMed ID: 8080674
[TBL] [Abstract][Full Text] [Related]
16. Study of efficacy and tolerability of tropisetron in the prevention of cisplatin induced nausea and vomiting.
Chiersilpa A; Ngow J
J Med Assoc Thai; 1999 Sep; 82(9):915-21. PubMed ID: 10561949
[TBL] [Abstract][Full Text] [Related]
17. A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis.
Madej G; Krzakowski M; Pawinski A; Lasota W; Rogowski W; Skoneczna I
Semin Oncol; 1994 Oct; 21(5 Suppl 9):3-6. PubMed ID: 9113119
[TBL] [Abstract][Full Text] [Related]
18. Tropisetron in the prevention of chemotherapy-induced nausea and vomiting in patients responding poorly to previous conventional antiemetic therapy.
Bruntsch U; Rüfenacht E; Parker I; Drechsler S; de Bruijn K
Ann Oncol; 1993; 4 Suppl 3():25-9. PubMed ID: 8363995
[TBL] [Abstract][Full Text] [Related]
19. Prevention of chemotherapy-induced nausea and emesis in patients responding poorly to previous antiemetic therapy. Comparing tropisetron with optimised standard antiemetic therapy.
Bruntsch U; Drechsler S; Hiller E; Eiermann W; Tulusan AH; Bühner M; Hartenstein R; Koenig HJ; Gallmeier WM
Drugs; 1992; 43 Suppl 3():23-6. PubMed ID: 1380429
[TBL] [Abstract][Full Text] [Related]
20. Current issues in the management of nausea and vomiting.
Gralla RJ
Ann Oncol; 1993; 4 Suppl 3():3-7. PubMed ID: 8363996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
